Researcher
Pieter Gillard
- Keywords:Medicine
Affiliations
- Diabetes Pathology & Therapy (Research group)
Member
From2 Feb 2011 → Today - Diabetes Clinic (Department)
Member
From1 Nov 2008 → Today - Clinical sciences (Department)
Member
From1 Oct 2023 → Today - Pathology/molecular and cellular medicine (Department)
Member
From1 Oct 2018 → 20 Oct 2022 - Pathology/molecular and cellular medicine (Department)
Member
From1 Aug 2014 → 30 Sep 2023 - Pathology/molecular and cellular medicine (Department)
Member
From1 Aug 2014 → 31 Jul 2018 - Internal medicine (Department)
Member
From1 Jan 2008 → 31 Jan 2008 - Department of Embryology and Genetics (Department)
Member
From1 Feb 2002 → 31 Jan 2006
Publications
51 - 60 of 65
- Plasma GAD65, marker for early beta cell loss following intraportal islet cell transplantation in diabetic patients(2015)
Authors: Zhidong Ling, Pieter De Pauw, Daniel Jacobs-Tulleneers Thevissen, Rui Mao, Pieter Gillard, Christiane S Hampe, Geert Martens, Pieter in 't Veld, Åke Lernmark, Bart Keymeulen, et al.
Pages: 2314-2321 - Early alteration of kidney function in non-uremic type 1 diabetic islet transplant recipients under tacrolimus-mycophenolate therapy(2014)
Authors: Pieter Gillard, Maria Rustandi, Achmad Efendi, Da Hae Lee, Zhidong Ling, Robert Hilbrands, Dirk Kuypers, Chantal Matthieu, Daniel Jacobs-Tulleneers Thevissen, Frans K Gorus, et al.
Pages: 451-457 - Minimal functional β-cell mass in intraportal implants that reduces glycemic variability in type 1 diabetic recipients(2013)
Authors: Pieter Gillard, Robert Hilbrands, Zhidong Ling, Da Hae Lee, Ilse Weets, Frans K Gorus, Christophe De Block, Leonard Kaufman, Chantal Mathieu, Danny Pipeleers, et al.
Pages: 3483-3488 - Predictive factors of allosensitization after immunosuppressant withdrawal in recipients of long-term cultured islet cell grafts(2013)
Authors: Robert Hilbrands, Pieter Gillard, C. Van Der Torren, Zhidong Ling, Sonja Verheyden, Daniel Jacobs-Tulleneers Thevissen, B. Roep, F. Claas, Christian Demanet, Frans K Gorus, et al.
Pages: 162-169 - Screening for insulinoma antigen 2 and zinc transporter 8 autoantibodies: a cost-effective strategy to identify relatives of type 1 diabetic patients with a high and age-independent progression rate to clinical onset.(2013)
Authors: Frans K Gorus, Eric V Balti, Ilse Vermeulen, Simke Demeester, Annelien Van Dalem, Olivier Costa, H. Dorchy, S. Tenoutasse, T. Mouraux, C. De Block, et al.
Pages: 82-90 - Immune responses against islet allografts during tapering of immunosuppression - a pilot study in 5 subjects(2012)
Authors: V. Huurman, C. Van Der Torren, Pieter Gillard, P. Van Der Meer-Prins, G. Duinkerken, Frans Claas, D. Roelen, B. Roep
Pages: 190-198 - Graves' hyperthyroidism after stopping immune suppressive treatment in type 1 diabetic islet cell recipients with pretransplant TPO autoantibodies.(2009)
Authors: Pieter Gillard, V. Huurman, Bart J Van der Auwera, B. Decallonne, Kris Poppe, B. Roep, C. Mathieu
Pages: 1817-1819 - Graves hyperthyroidism after stopping immunosuppressive therapy in type 1 diabetic Islet cell recipients with pretransplant TPO autoantibodies(2009)
Authors: Pieter Gillard, Volkert Huurman, Brigitte Decallonne, Kris Poppe, Bart O Roep, Chantal Mathieu
Pages: 1817-1819 - Comparison of sirolimus alone with sirolimus plus tacrolimus in type 1 diabetic recipients of cultured islet cell grafts(2008)
Authors: Pieter Gillard, Zhidong Ling, Chantal Mathieu, Laurent Crenier, Matthias Lannoo, Bart Maes, Bart O Roep, Frans K Gorus, Danny Pipeleers, Bart Keymeulen
Pages: 256-263 - Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation.(2008)
Authors: V. Huurman, Robert Hilbrands, Gg Pinkse, Pieter Gillard, G. Duinkerken, P Van De Linde, E. Van Der Meer-Prins, M. Versteeg-Van Der Voort Maarschalk, Koen Verbeeck, B. Alizadeh, et al.
Pages: 1-10